Liquidia is deeply passionate and committed to the discovery, engineering, and development required to bring novel therapies to patients who need them most, and to the healthcare providers who care for them. Our current drive is toward improving the treatment of pulmonary hypertension (PH). We will continue to combine our proprietary, innovative PRINT® Technology with new and established medications, offering the potential for both better precision and improved clinical outcomes. Our team members include some of the industry’s top scientists, clinicians, business strategists, engineers, and pharmaceutical executives. We work together to help people lead longer, healthier, and happier lives.
The Principal Specialist, Quality Operations is a senior individual contributor within Quality Assurance who provides advanced quality, compliance, and technical leadership across Liquidia's GxP operations. This role serves as a key quality partner supporting manufacturing, quality control, product quality, quality systems, and other operational functions to ensure compliance with regulatory requirements and company quality standards.
This position is expected to operate with a high degree of independence, sound judgment, and a risk-based mindset while addressing a broad range of quality and operational challenges. As a recognized subject matter expert, the Principal Specialist leads and supports complex quality activities, drives continuous improvement initiatives, contributes to strategic quality objectives, and provides technical guidance across the organization.
The role is well suited for a hands-on quality professional who thrives in a dynamic environment, is comfortable wearing multiple hats, and can effectively balance day-to-day operational support with longer-term quality and compliance initiatives. While the position does not include formal people management responsibilities, it requires significant influence, collaboration, and mentorship across functions.
Liquidia offers a competitive compensation package as well as a comprehensive benefits package that includes Medical, Dental, Vision, STD, LTD, 401(k) Savings Retirement Plan, ESPP, and more!
Liquidia is an equal opportunity employer. Qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status. Reasonable accommodation may be made to enable qualified individuals with disabilities to perform the essential functions of this position.
Liquidia will not accept unsolicited assistance from recruiting/search agencies for this employment opportunity. Please, no phone calls or emails. All resumes submitted by recruiting or search agencies to any employee at Liquidia via email, the Internet or in any form and/or method without a valid written search/recruitment agreement in place for this position will be deemed the sole property of Liquidia. No fee will be paid in the event the candidate is hired by Liquidia as a result of the referral or through other means.
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. Liquidia has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). Liquidia is also developing L606, an investigational liposomal formulation of treprostinil administered twice-daily with a short-duration next-generation nebulizer, for use in North America. The subsidiary Liquidia PAH provides for the commercialization of pharmaceutical products to treat pulmonary disease, such as generic Treprostinil Injection.
